Steven M. Smith, PharmD, MPH, BCPS

Steven Smith

Steven M. Smith, PharmD, MPH, BCPS
Assistant Professor of Pharmacy and Medicine
Pharmacotherapy & Translational Research
Community Health & Family Medicine
1707 North Main Street
Gainesville, FL 32609

Contact Information
Phone: (352) 273-5134
Fax: (352) 265-9584

Professional Biography

Dr. Steven M. Smith is an Assistant Professor in the Departments of Pharmacotherapy & Translational Research (Pharmacy) and Community Health & Family Medicine (Medicine). His primary responsibilities in the department are research-related and Co-Directing the Pharmacy Fellowship in Family Medicine Clinical Research. Dr. Smith’s research is focused in the areas of cardiovascular pharmacotherapy, particularly hypertension, and health services research related to pharmacist involvement in direct management of patients in the ambulatory care setting.

Dr. Smith received his PharmD from the UF College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine Clinical Research and was invited to be an Advanced Postgraduate Program in Clinical Investigation (APPCI) fellow, during which time he received a Master’s of Public Health through the College of Public Health and Health Professions at UF. Dr. Smith then joined the faculty at the University of Colorado in 2011 and was subsequently invited to be a CU Clinical Faculty Scholar in 2013. In 2014, he rejoined the University of Florida as faculty with a joint appointment in Pharmacy and Medicine.


PharmD University of Florida, Gainesville, FL Pharmacy
MPH University of Florida, Gainesville, FL Biostatistics/Epidemiology
Residency NF/SG Veterans Affairs Health System, Gainesville, FL Pharmacy Practice
Fellowship University of Florida, Gainesville, FL Family Medicine Clinical Research

Certifications and Professional Organizations

  • Board Certified Pharmacotherapy Specialist (BCPS)
  • American Society of Hypertension
  • American Heart Association
  • American College of Clinical Pharmacy
  • American Association of Colleges of Pharmacy

Honors and Awards

Recent Publications

  • Smith SM, Pepine CJ, Cooper-DeHoff RM. Reply to ‘Resistant hypertension revisited: definition and true prevalence’. J Hypertens. 2014 Jul
  • Rosenwasser RF, Shah NK, Smith SM, Wen X, Gong Y, Gums JG, Nichols WW, Chapman AB, Boerwinkle E, Johnson J, Epstein B. Baseline predictors of central aortic blood pressure: a PEAR substudy.J Am Soc Hypertens. 2014 Mar
  • Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, Noel Bairey Merz C, Pepine CJ, Cooper-Dehoff RM. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.J Am Heart Assoc. 2014 Feb 28
  • Smith SM, Gong Y, Handberg E, Messerli FH, Bakris GL, Ahmed A, Bavry AA, Pepine CJ, Cooper-Dehoff RM. Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.J Hypertens. 2014 Mar
  • Smith SM, Campbell JD. Cost-Effectiveness of Renin-Guided Treatment of Hypertension.Am J Hypertens. 2013 Sep 18.
  • Smith SM. Epidemiology, prognosis, and treatment of resistant hypertension.Pharmacotherapy. 2013 Oct. Epub 2013 May 30.
  • Evans JG, Sutton DR, Dajani LH, Magee JS, Silva RA, Roura MF, Wadud K, Purcell JA, Travaglini S, Segel SA, Sultan S, Roffman MS, Ayad SS, Borja-Hart NL, Smith SM. A novel endocrinology-based wellness program to reduce medication expenditures and improve glycemic outcomes.Diabetes Metab Syndr. 2013 Apr-Jun. Epub 2013 Mar 22.
  • Nuffer W, Smith SM, Trinkley K. Integrating virtual reality to expand the public health role of community pharmacists.J Am Pharm Assoc (2003). 2013 Mar-Apr.
  • Smith SM, Meyer M, Trinkley KE. Phentermine/topiramate for the treatment of obesity.Ann Pharmacother. 2013 Mar
  • Shah NK, Smith SM, Nichols WW, Lo MC, Ashfaq U, Satish P, Johnson JA, Epstein BJ. Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study).J Clin Hypertens (Greenwich). 2011 Dec. Epub 2011 Nov 7.